Ohio becomes the 21st state to prohibit OTC sales of drugs containing the cough suppressant dextromethorphan to minors as the number of US youths abusing the ingredient increased in 2020, particularly in the youngest group surveyed, eighth-grade students.
Ohio’s sales restriction, which takes effect on 29 September, prohibits the sale of DXM-containing products to minors without a prescription.





